Stemtech Corp (STEK) stock
STEKOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $296.22KP/E –Yield –
Stemtech operating margin
Operating margin is operating income as a percentage of revenue.
Stemtech's operating margin for the twelve months ending Sep 30, 2026 was -134.0%. For fiscal 2025 it was -94.2%, against -47.2% the year before. The highest annual figure on record is -47.2% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -94.2% | −47.0 |
| FY2024 | Dec 31, 2024 | -47.2% | +38.6 |
| FY2023 | Dec 31, 2023 | -85.8% | +24.3 |
| FY2022 | Dec 31, 2022 | -110.2% | −35.9 |
| FY2021 | Dec 31, 2021 | -74.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | -131.5% | −91.7 |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -20.0% | +23.2 |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -236.4% | −97.6 |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -188.6% | −191.1 |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -39.8% | +29.7 |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -43.1% | +9.1 |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -138.8% | −65.7 |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | 2.5% | +107.3 |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -69.5% | −24.9 |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -52.2% | +33.6 |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -73.1% | +37.3 |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -104.8% | −64.8 |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -44.6% | +278.5 |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -85.8% | −5.2 |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -110.4% | −94.8 |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -40.0% | −33.1 |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -323.0% | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -80.6% | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -15.6% | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -7.0% | – |
See a number that looks wrong?